Sign in
4

Changes in Ownership

Arcus Biosciences, Inc. Filed Acc 0001671311-25-000005

Chief Operating Officer sold 50,291 shares at $18.97 ($954,066)

  • Chief Operating Officer acquired 50,291 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Jarrett Jennifer · Chief Operating Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-11-07 Exercise or conversion : show line 1 in the form 10b5-1 +50,291 $1.23 $61,737 264,523 D
2025-11-07 Sale : show line 2 in the form 10b5-1 −50,291 $18.97 $954,066 214,232 D
Open-market sales · 50,291 sh · avg $18.97 · $954,066

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-11-07 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −50,291 $1.23 $61,737 80,583 D
Loading xslF345X05/wk-form4_1762981456.xml…